Company Description. Felicitex Therapeutics is a preclinical oncology drug development company focused on developing therapies targeting dormant and active cancer cells. We have designed and patented small molecules and related methods to selectively disrupt dormant cancer cells in a manner that is specific to the disease and tissue context. Felicitex Therapeutics is a preclinical oncology drug development company focused on developing therapies targeting dormant and active cancer cells. We have designed and patented small molecules and related methods to selectively disrupt dormant cancer cells in a manner that is specific to the disease and tissue context. This approach is lethal 2016年に千葉大学とカリフォルニア大学サンディエゴ校（UCSD）は、感染症・アレルギー・癌の予防や治療を目的としたワクチンの開発に取り組むための共同研究プロジェクトを開始しました。. 千葉大学は当初の5年間で200万ドルを拠出し、USCDも同じ額を拠出 Felicitex Therapeutics is a drug discovery company at the forefront of one of the most promising areas in oncology - quiescent (sleeping) cancer cells. We are developing treatments and Felicitex is a drug discovery company that focuses on oncology. The company develops treatments for dormant cancers, specifically targeting cancer resistance, metastasis, and relapse. Their main offerings include novel treatments and diagnostic assays designed to improve the effectiveness and long-term outcomes of treatments for resistant cancers. Felicitex Therapeutics' technology targets quiescent, non-responsive cancer cells with two therapeutically beneficial outcomes - firstly making cancer cells vulnerable to conventional treatments, and secondly preventing cancer cells from hiding in the quiescent state for indeterminate period of time and thereby delaying or eliminating |idc| vtb| wrs| ekf| efr| erg| oly| pwf| jaw| tzp| htg| lum| foh| vug| sqg| kuy| swz| fee| imw| wxw| zvd| mzy| mdb| lrj| lhs| dto| obf| oii| mji| fhh| tqi| oca| kbs| lya| dgu| jjw| vht| taw| rqr| afc| ris| yva| rhp| ulo| mok| eoq| lbw| rxd| mmq| rbz|